Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Germline EGFR mutations in lung cancer (Review)
Minghui Liu, Xiaoyu Niu, Hongyu Liu, et al.
Oncology Letters (2023) Vol. 26, Iss. 1
Open Access | Times Cited: 10

Showing 10 citing articles:

Nrf2 signaling pathway: current status and potential therapeutic targetable role in human cancers
Lin Li, Qing Wu, Feifei Lu, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 42
From Rarity to Reality: Osimertinib's Promising Horizon in Treating Uncommon EGFR Mutations in Non-Small Cell Lung Cancer
Akito Fukuda, Yusuke Okuma
Clinical Cancer Research (2024) Vol. 30, Iss. 15, pp. 3128-3136
Closed Access | Times Cited: 5
Incidental pathogenic germline alterations detected through liquid biopsy in patients with solid tumors: prevalence, clinical utility and implications
Juan Carlos Laguna, B. Pastor, I. Nalda, et al.
British Journal of Cancer (2024) Vol. 130, Iss. 9, pp. 1420-1431
Closed Access | Times Cited: 3
Mutational characteristics and clinical outcomes for lung adenocarcinoma with EGFR germline mutations
Kelsey Pan, Jennifer Owens, Yasir Y. Elamin, et al.
Journal of Thoracic Oncology (2024)
Closed Access | Times Cited: 3
Current status of molecular diagnostics for lung cancer
Evgeny N. Imyanitov, Elena V. Preobrazhenskaya, С. В. Орлов
Exploration of Targeted Anti-tumor Therapy (2024) Vol. 5, Iss. 3, pp. 742-765
Open Access | Times Cited: 2
Recombinant retroviral vectors that express EGF, TGF alpha, NRG2 beta, and the NRG2 beta Q43L mutant v2
Ella Wilson
(2024)
Open Access | Times Cited: 1
Characterization of Incidental Pathogenic Germline Findings Detected via ctDNA among Patients with Non-Small Cell Lung Cancer in a Predominantly Hispanic/Latinx Population
Esha Vallabhaneni, Samuel A. Kareff, Reagan Barnett, et al.
Cancers (2024) Vol. 16, Iss. 6, pp. 1150-1150
Open Access | Times Cited: 1
The rapidly changing field of predictive biomarkers of non-small cell lung cancer
László Tóth, Attila Mokánszki, Gábor Méhes
Pathology & Oncology Research (2024) Vol. 30
Open Access | Times Cited: 1
A patient with a germline (p.R776H) EGFR mutation with multiple lung cancers harboring different somatic EGFR mutations.
Iacopo Petrini, Rossella Bruno, Iosè Di Stefano, et al.
Clinical Lung Cancer (2024) Vol. 25, Iss. 5, pp. e238-e242
Open Access
Benefits of osimertinib treat a lung adenocarcinoma patient with germline EGFR T790M, somatic EGFR 19-Del, TP53 and PIK3CA mutations
Yingxue Li, Guangqi Li, Zheng Zheng, et al.
Hereditary Cancer in Clinical Practice (2024) Vol. 22, Iss. 1
Open Access
Page 1

Scroll to top